Akebia Therapeutics
AKBA
$2.73
Share price
-4.23%
Change (1 day)
-8.43%
Change (1 year)
Categories
EPS for Akebia Therapeutics (AKBA)
EPS in 2023 (TTM): -$0.88
According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.86. In 2022 the company made an earnings per share (EPS) of -$0.68 an increase over its 2021 EPS that were of -$2.28.
EPS history for Akebia Therapeutics from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.88 | 29.54% |
| 2022 | -$0.68 | -70% |
| 2021 | -$2.28 | -38.63% |
| 2020 | -$3.71 | 17.37% |
| 2019 | -$3.16 | 2.79% |
| 2018 | -$3.07 | 31.2% |
| 2017 | -$2.34 | -51.39% |
| 2016 | -$4.82 | 57.89% |
| 2015 | -$3.05 | -94.83% |
| 2014 | -$59.05 | 589.75% |
| 2013 | -$8.56 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | $18.94 | -2,310.94% | 🇺🇸 USA |
 | $5.01 | -684.38% | 🇨🇭 Switzerland |
 | $18.86 | -2,300.83% | 🇺🇸 USA |
 | -$2.18 | 154.69% | 🇺🇸 USA |